The presence of hexacosanol was found to be competent in averting kidney impairment by modulating the expression of nitric oxide synthase [58] and protein kinase C (PKC) [59], leading to the inhibition of glomerular sclerosis and improvement of diabetic neuropathy [58,59]. This evidence concerns the gene PRRT2 and diabetic neuropathy.